Ghodsizad Ali, Badiye A, Zeriouh M, Pae W, Koerner M M, Loebe M
Heart and Vascular Institute, Penn State Milton S. Hershey Medical Center, Penn State College of Medicine, Hershey, Pennsylvania, USA.
Miami Transplant Institute, University of Miami, Jackson Memorial Hospital, Miami, Florida, USA.
Heart Surg Forum. 2016 Dec 14;19(6):E284-E285. doi: 10.1532/hsf.1636.
Despite advances in pump technology, thromboembolic events and pump thrombosis are potentially life-threatening complications in patients with continuous flow ventricular assist devices. Here we describe a patient with pump thrombosis following LVAD HeartMate II implantation presenting with Aspirin and Plavix resistance and signs of acute hemolysis as manifested by high LDH, changing pump power, pulse index and reduced pump flows.
尽管泵技术有所进步，但在使用连续流心室辅助装置的患者中，血栓栓塞事件和泵血栓形成仍是潜在的危及生命的并发症。在此，我们描述了一名在植入左心室辅助装置（LVAD）HeartMate II后发生泵血栓形成的患者，该患者表现出对阿司匹林和氯吡格雷耐药，并出现急性溶血迹象，如乳酸脱氢酶（LDH）升高、泵功率变化、脉冲指数改变以及泵流量降低。
